SII seeks permission for phase-3 study of Covid vaccine Covovax as booster dose in adults
India | February 27, 2022 19:22 ISTPrakash Kumar Singh, Director, Government and Regulatory Affairs at SII had last week submitted an application to DCGI seeking nod for phase-3, observer-blind, randomised, controlled study to evaluate the safety and immunogenicity of Covovax as booster dose.